Curanex Pharmaceuticals Inc (CURX)
$0.30
$-0.01
(-4.03%)
As on 15-May-2026 16:00EDT
Market cap
$9 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.9 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
0
-
Book Value
$0
-
EPS
$--
-
Face value
--
-
Shares outstanding
28,340,812
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Curanex Pharmaceuticals Inc (CURX)
| -9.2 | -35.1 | 5.0 | -- | -- | -- | -- |
|
BSE Sensex*
| -11.1 | -4.0 | -9.7 | -8.5 | 7.0 | 8.7 | 11.3 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Curanex Pharmaceuticals Inc (CURX)
|
0.3 | 8.5 | 0.0 | -7.2 | -- | -64.7 | -- | 0.8 |
| 38.5 | 9,641.3 | 5,360.0 | -146.0 | 8.3 | -1.6 | -- | 1.1 | |
| 8.2 | 718.9 | 148.5 | 33.7 | 37.5 | 29.6 | 20 | 4.7 | |
| 20.2 | 946.9 | 1,175.0 | 38.6 | 7.3 | -- | 11.4 | 0.8 | |
| 11.2 | 1,212.9 | 34.8 | 20.3 | 0.0 | 9.1 | 53.2 | 5.7 |
Shareholding Pattern
View DetailsAbout Curanex Pharmaceuticals Inc (CURX)
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including... ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York. Read more
-
CEO, President & Chairman
Mr. Jun Liu
-
CEO, President & Chairman
Mr. Jun Liu
-
Headquarters
Jericho, NY
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Curanex Pharmaceuticals Inc (CURX)
What is the current share price of Curanex Pharmaceuticals Inc (CURX) Today?
The share price of Curanex Pharmaceuticals Inc (CURX) is $0.30 (NASDAQ) as of 15-May-2026 16:00 EDT. Curanex Pharmaceuticals Inc (CURX) has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Curanex Pharmaceuticals Inc (CURX)?
Since, TTM earnings of Curanex Pharmaceuticals Inc (CURX) is negative, P/E ratio is not available.
The P/B ratio of Curanex Pharmaceuticals Inc (CURX) is 0.82 times as on 15-May-2026, a 27 discount to its peers’ median range of 1.12 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-1.96
|
0.74
|
|
2024
|
--
|
--
|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
|
2025
|
-1.96
|
0.74
|
What is the 52 Week High and Low of Curanex Pharmaceuticals Inc (CURX)?
The 52-week high and low of Curanex Pharmaceuticals Inc (CURX) are Rs 9.18 and Rs 0.27 as of 18-May-2026.
What is the market cap of Curanex Pharmaceuticals Inc (CURX)?
Curanex Pharmaceuticals Inc (CURX) has a market capitalisation of $ 9 Mln as on 15-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Curanex Pharmaceuticals Inc (CURX)?
Before investing in Curanex Pharmaceuticals Inc (CURX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.